Stem cells against viral hepatitis
The aim of phase II clinical trials is to evaluate the effectiveness of the allogeneic mesenchymal bone marrow stem cell transplantation technique in patients with hepatic insufficiency caused by the hepatitis B virus.
27.04.2011